Literature DB >> 7060853

The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics.

R J Jarrett, P McCartney, H Keen.   

Abstract

Mortality rates from coronary heart disease and from all causes have been ascertained over ten years in three groups of people participating in the Bedford Survey--newly-diagnosed diabetics, borderline diabetics and control subjects with normal glucose tolerance. Age corrected mortality rates, from all causes and coronary heart disease, were highest in the diabetics and intermediate in the borderline diabetics and in both groups were similar in men and women. When statistical allowance was made for baseline differences in age, blood pressure and obesity, female borderline diabetics still had a significantly increased risk over their controls of death from 'all causes'. Much of the difference appeared to be due to a relative excess of deaths due to coronary heart disease. It is concluded that borderline diabetes (or impaired glucose tolerance) is associated with a relatively greater increase in mortality risk in women than men. During the 10-year follow-up of the Bedford borderline diabetics, coronary heart disease morbidity and mortality rates were similar in men and women. Age at entry to the study was the major independent and significant predictor of mortality from all causes. The level of systolic blood pressure and current cigarette smoking at baseline were statistically significant predictors only of mortality due to coronary heart disease.

Entities:  

Mesh:

Year:  1982        PMID: 7060853     DOI: 10.1007/bf00254833

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  Estimation of the probability of an event as a function of several independent variables.

Authors:  S H Walker; D B Duncan
Journal:  Biometrika       Date:  1967-06       Impact factor: 2.445

2.  Asymptomatic hyperglycemia and coronary heart disease. A series of papers by the International Collaborative Group, based on studies in fifteen populations. Introduction.

Authors: 
Journal:  J Chronic Dis       Date:  1979

3.  The consomitants of raised blood sugar: studies in newly-detected hyperglycaemics. II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels.

Authors:  H Keen; C Chlouverakis; J Fuller; R J Jarrett
Journal:  Guys Hosp Rep       Date:  1969

4.  The concomitants of raised blood sugar: studies in newly-detected hyperglycaemics. I. A comparative assessment of neurological functions in blood sugar groups.

Authors:  R J Jarrett; H Keen; D R Boyns; C Chlouverakis; J Fuller
Journal:  Guys Hosp Rep       Date:  1969

5.  Hyperglycaemia and coronary heart disease: the Whitehall study.

Authors:  J H Fuller; P McCartney; R J Jarrett; H Keen; G Rose; M J Shipley; P J Hamilton
Journal:  J Chronic Dis       Date:  1979

6.  The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes.

Authors:  H Keen; R J Jarrett; P McCartney
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

7.  Treatment of borderline diabetes: controlled trial using carbohydrate restriction and phenformin.

Authors:  R J Jarrett; H Keen; J H Fuller; M McCartney
Journal:  Br Med J       Date:  1977-10-01

8.  Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.

Authors:  T A Welborn; K Wearne
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

9.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  63 in total

Review 1.  Impact of dyslipidaemia. Lessons from clinical trials.

Authors:  W V Brown
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

Review 2.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 3.  Hypertension in non-insulin dependent diabetes mellitus and its management.

Authors:  M D Feher
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 4.  Impaired glucose tolerance.

Authors:  J S Yudkin; K G Alberti; D G McLarty; A B Swai
Journal:  BMJ       Date:  1990-09-01

5.  The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus.

Authors:  K Borch-Johnsen; P K Andersen; T Deckert
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

6.  Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study.

Authors:  A Rosengren; L Welin; A Tsipogianni; L Wilhelmsen
Journal:  BMJ       Date:  1989-11-04

Review 7.  Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease-chicken, egg or neither?

Authors:  R J Jarrett
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

8.  Prevalence of diabetes mellitus in elderly men aged 65 to 84 years in eastern and western Finland.

Authors:  J Tuomilehto; A Nissinen; S L Kivelä; J Pekkanen; E Kaarsalo; E Wolf; A Aro; S Punsar; M J Karvonen
Journal:  Diabetologia       Date:  1986-09       Impact factor: 10.122

9.  Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects.

Authors:  M Uusitupa; O Siitonen; A Aro; K Pyörälä
Journal:  Diabetologia       Date:  1985-01       Impact factor: 10.122

10.  Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.

Authors:  M Farrer; F L Game; C J Albers; H A Neil; P H Winocour; M F Laker; P C Adams; K G Alberti
Journal:  BMJ       Date:  1993-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.